Insulins and analogs
Insulins and analogs has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Aug 29, 2022: “Identifying Protective Drugs for Parkinson's Disease in Health-Care Databases Using Machine Learning”.
1 paper studies it1 findingUpdated
See all 1 papers on insulins and analogs
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Other signals included adrenergics in combination with anticholinergics (R03AL) and insulins and analogues (A10AD).”
- 1 lab in 1 country
- Funders: The Michael J. Fox Foundation for Parkinson's Research and 1 more
- Humans1
What is insulins and analogs linked with?
1Studies link insulins and analogs with Parkinson's disease risk.
Parkinson's disease risk
downin humans1
1 study
Parkinson's disease risk
downin humans1
Insulins and analogs are associated with Parkinson's disease risk in humans.
“Other signals included adrenergics in combination with anticholinergics (R03AL) and insulins and analogues (A10AD).”
Humans2-year exposure period starting 10 years before the index date
Identifying Protective Drugs for Parkinson's Disease in Health-Care Databases Using Machine Learning
Movement disorders : official journal of the Movement Disorder Society